A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
16 Jul 2020	Submitted	Original manuscript
20 Jul 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
26 Jul 2020	Editorially accepted
5 Aug 2020	Article published	10.1186/s13063-020-04632-4

Back to article page